Kitten Vaccination Schedule

The kitten vaccination schedule determines when each vaccine is administered during the critical first 16 weeks of life, targeting the narrowing window between maternal antibody decline and the establishment of independent immunity.

A kitten is born with an immune system that cannot yet protect itself. For the first weeks of life, protection comes entirely from the queen — antibodies transferred through colostrum (the protein-rich first milk) during the first 24 hours after birth. These maternal antibodies provide a temporary shield against the diseases the queen herself is immune to. The shield is effective but temporary, and it creates a paradox that shapes the entire vaccination schedule: the same antibodies that protect the kitten from infection also prevent vaccines from working.

Understanding this paradox — and the immunological logic behind the vaccination timeline — helps explain why kittens need multiple doses, why timing matters, and why missing a dose has consequences that a delayed human flu jab does not. The personalised vaccination planner generates an individual schedule based on your kitten's age and location. This guide explains the science behind those dates.

Maternal Antibodies: The Protective Paradox

Within the first 24 hours of life, a kitten's gut is uniquely permeable to large protein molecules — including whole antibodies (immunoglobulins) present in colostrum. This window of intestinal permeability closes permanently around 24 hours after birth, after which the gut matures and can no longer absorb intact antibodies. Kittens that miss the colostrum window (orphaned, rejected, or born to an unvaccinated queen) have significantly reduced passive immunity and are at higher risk of early-life infection.

The antibodies absorbed from colostrum are primarily IgG — the same class of antibody that vaccines aim to stimulate the kitten's own immune system to produce. Herein lies the problem: when a vaccine is administered, it introduces a controlled amount of antigen (killed or modified-live virus) to stimulate an immune response. If maternal IgG antibodies are still circulating at high levels, they bind to and neutralise the vaccine antigen before the kitten's own B-cells and T-cells can recognise and respond to it. The vaccine, in effect, is intercepted before it can do its job.

Maternal antibody levels decline at a predictable but individually variable rate. The half-life of maternally derived IgG in kittens is approximately 14 to 16 days. For most kittens, maternal antibodies fall below the protective threshold between 8 and 12 weeks of age. However, a significant minority of kittens — particularly those born to queens with very high antibody titres — retain interfering maternal antibodies until 14 to 16 weeks. This individual variation is the fundamental reason why the primary vaccination course requires three doses spread across the 6 to 16 week window, rather than a single dose at a fixed age.

The Core Vaccines: What They Protect Against

Core vaccines are recommended for every kitten regardless of lifestyle, geographic location, or intended indoor-outdoor status. The diseases they prevent are sufficiently severe, sufficiently prevalent, or sufficiently environmentally persistent that all cats face meaningful exposure risk.

Feline Panleukopenia (Feline Parvovirus — FPV)

Panleukopenia is the most dangerous disease in the core vaccination programme. The virus attacks rapidly dividing cells — primarily the bone marrow and intestinal lining — causing severe vomiting, bloody diarrhoea, profound immunosuppression (the "panleukopenia" refers to a dramatic drop in white blood cells), and dehydration. Mortality in unvaccinated kittens exceeds 90% in some studies. The virus is extraordinarily environmentally stable: it can survive on surfaces for over a year, resists most household disinfectants, and can be carried into the home on shoes, clothing, and hands without any direct cat contact.

This environmental persistence is why indoor-only kittens still need panleukopenia vaccination. The virus does not require your kitten to meet an infected cat. It requires only that the virus reaches your home — on a shoe that walked through contaminated soil, on a hand that touched an infected surface, or in a shelter environment before adoption. Panleukopenia vaccination is non-negotiable for every kitten.

Feline Calicivirus (FCV)

Calicivirus causes upper respiratory disease — sneezing, nasal discharge, conjunctivitis — and, distinctively, oral ulceration. Ulcers on the tongue, gums, and palate cause significant pain and reluctance to eat. Most cats recover from acute calicivirus infection, but a proportion become chronic carriers that shed the virus intermittently for months or years, creating an ongoing transmission risk in multi-cat environments. Rarely, a hypervirulent strain causes VS-FCV — a severe systemic disease with high mortality that has caused outbreaks in veterinary clinics and shelters.

Calicivirus vaccination does not prevent infection in all cases — the virus has many strains, and no vaccine covers all of them. Vaccination does reduce the severity and duration of disease, which is clinically meaningful even if it does not provide sterilising immunity.

Feline Herpesvirus (Feline Viral Rhinotracheitis — FHV-1)

Herpesvirus is the other major cause of upper respiratory disease in cats, producing sneezing, nasal congestion, conjunctivitis, and fever. After recovery from the acute infection, virtually all infected cats become lifelong carriers. The virus establishes latency in the trigeminal nerve ganglia and can reactivate during periods of stress (boarding, rehoming, introduction of new household cats, illness), causing recurrent episodes of respiratory disease and viral shedding.

As with calicivirus, vaccination reduces disease severity rather than preventing infection entirely. An unvaccinated kitten with herpesvirus develops severe, potentially life-threatening respiratory disease. A vaccinated kitten exposed to the same virus typically develops mild, self-limiting symptoms or no clinical disease at all. The FVRCP combination vaccine covers panleukopenia, calicivirus, and herpesvirus in a single injection.

Week-by-Week Vaccination Timeline

The following schedule follows the 2024 WSAVA vaccination guidelines, which represent the current international consensus on feline vaccination timing. Minor variations exist between individual veterinary practices, and your vet may adjust timing based on local disease prevalence, the specific vaccine product used, and your kitten's individual risk factors.

The three-dose FVRCP schedule exists because of the maternal antibody variability described above. The first dose at 6 to 8 weeks may work in some kittens but will be blocked by maternal antibodies in others. The second dose at 10 to 12 weeks catches the majority. The third dose at 14 to 16 weeks is the safety net — it ensures that even kittens with unusually persistent maternal antibodies receive at least one effective dose before the course ends. Removing the third dose to save cost or inconvenience risks leaving a proportion of kittens unprotected.

The kitten age converter helps track developmental milestones alongside the vaccination schedule, particularly for owners unsure of their kitten's exact age (common in rescue and stray kittens).

FeLV: The 2024 WSAVA Position Shift

FeLV causes immunosuppression, anaemia, and lymphoma in cats. Transmission occurs through prolonged close contact — mutual grooming, shared food bowls, bite wounds — and from queen to kittens during pregnancy or nursing. An infected cat may appear healthy for months or years before clinical disease develops, making testing before vaccination essential: vaccinating a cat that is already FeLV-positive provides no benefit and may confuse future diagnostic testing.

Historically, FeLV vaccination was classified as "non-core" — recommended only for cats with outdoor access or known exposure risk. The 2024 WSAVA guidelines shifted this position. FeLV vaccination is now recommended for all kittens during the primary course, regardless of intended lifestyle. The rationale is pragmatic rather than theoretical.

• Lifestyle plans change: an indoor kitten may become an indoor-outdoor cat when the household moves, or may escape through an open window or door
• Rehoming is common: approximately 15% of cats are rehomed at least once during their lifetime, often into households with different access arrangements
• New cat introductions happen: a household that starts with one indoor kitten may add a second cat whose FeLV status was not tested or was tested during the unreliable early window
• The primary FeLV course (two doses in kittenhood) carries minimal risk and modest cost, while the consequence of FeLV infection is severe and often fatal

The shift applies to the kitten primary course. Whether to continue FeLV boosting into adulthood remains a risk-based decision. Indoor-only adult cats with no FeLV-positive housemates and no outdoor access may reasonably discontinue FeLV boosters after the first-year booster at 15 to 16 months. Outdoor cats, cats in multi-cat households with new additions, and cats in areas with high FeLV prevalence should continue receiving FeLV boosters according to the schedule generated by the personalised vaccination planner.

UK vs US Schedule Differences

The core vaccination principles are identical — protect against panleukopenia, calicivirus, and herpesvirus using a multi-dose primary course. The practical differences reflect legal requirements and regional disease prevalence rather than fundamental disagreements about immunology.

The most notable difference is rabies vaccination. The UK has been rabies-free since 1922 (excepting a single bat-strain case in 2002), and routine rabies vaccination is neither required nor recommended for domestic cats. In the US, rabies vaccination is a legal requirement in most states, driven by the ongoing presence of rabies in wildlife populations (raccoons, skunks, bats, foxes). UK owners travelling internationally with their cat via the Pet Travel Scheme require rabies vaccination at least 21 days before travel.

For breeders tracking litters, the queen pregnancy tracker helps coordinate expected birth dates with the kitten vaccination schedule, ensuring the primary course can begin at the appropriate age.

Indoor vs Outdoor Kittens: Does Lifestyle Change the Schedule?

The primary vaccination course is identical for indoor and outdoor kittens. Core vaccines protect against diseases that do not respect walls and doors — panleukopenia virus can survive on surfaces for over a year and enters homes on contaminated objects, while calicivirus and herpesvirus can be transmitted at veterinary clinics, boarding facilities, and through brief nose-to-nose contact at windows or doors.

Where lifestyle affects vaccination decisions is in the non-core category and in adult booster scheduling.

• FeLV boosting beyond the first year: Indoor-only cats with no new cat introductions planned may discontinue FeLV boosters after the first annual booster. Outdoor cats should continue FeLV vaccination on the schedule recommended by their vet.
• Chlamydophila felis vaccination: Relevant only for multi-cat environments with confirmed Chlamydophila infection. Not routinely recommended for single indoor cats.
• Bordetella bronchiseptica: Occasionally recommended for cats in high-density environments (shelters, large multi-cat households). Not a standard kitten vaccine.

The core FVRCP course and timing are non-negotiable regardless of lifestyle. An indoor kitten that misses its primary vaccination course is not safe — it is unprotected and relying on an absence of exposure that cannot be guaranteed. New kittens entering the household should be fully vaccinated and ideally tested for FeLV and FIV before introduction to resident cats. The household safety guide for new kitten owners covers additional safety considerations beyond vaccination for new kitten households.

After the Primary Course: Boosters and Long-Term Immunity

The first annual booster — given at 15 to 16 months of age, approximately 12 months after the final primary dose — is a critical part of the vaccination programme. It is not merely a repeat dose. The first-year booster confirms that long-term immunological memory has been established and extends the duration of protection from months to years. A kitten that completes its primary course but misses the first-year booster may have weaker, shorter-lasting immunity than one that receives all four doses on schedule.

After the first-year booster, the recommended frequency for core vaccines shifts to triennial (every 3 years) for most cats, based on duration-of-immunity studies showing that FVRCP vaccines provide protection for at least 3 years and often longer. Some practices still recommend annual core vaccination; the WSAVA position is that triennial boosting provides adequate protection while reducing unnecessary vaccination frequency.

The kitten feeding programme runs parallel to the vaccination schedule and deserves equal attention during this growth period. A kitten feeding calculator adjusts calorie targets for the rapid growth rate between 2 and 6 months of age, when kittens may need up to three times the calorie density per kilogram of body weight compared to adult cats.

FeLV and rabies (where applicable) have their own booster schedules. FeLV boosters are typically given annually for at-risk cats, though some newer FeLV vaccines are labelled for biennial (every 2 years) use. Rabies boosters follow a 1-year initial booster, then triennial schedule in most US jurisdictions, though local laws may require annual rabies vaccination.

What Can Go Wrong: Vaccine Reactions and Side Effects

Vaccination reactions in kittens are uncommon and overwhelmingly mild. The most frequently reported effects are transient lethargy (sleeping more than usual for 24 to 48 hours), mild soreness at the injection site, a slight temperature elevation, and reduced appetite for a day. These are normal immune responses and resolve without treatment.

Serious adverse reactions — anaphylaxis, persistent injection-site swelling, or severe systemic illness — are rare, occurring in fewer than 1 in 10,000 vaccinated cats according to pharmacovigilance data. FISS (feline injection-site sarcoma) is an aggressive tumour that develops at the vaccination site in an extremely small proportion of cats, estimated at 1 in 10,000 to 1 in 30,000 vaccinations depending on the study. Modern vaccination protocols mitigate FISS risk by rotating injection sites, using non-adjuvanted vaccines where available, and administering vaccines in limb locations rather than the interscapular region (between the shoulder blades) so that surgical excision with wide margins is possible if a sarcoma develops.

The risk of vaccine-preventable disease in an unvaccinated kitten dramatically outweighs the risk of vaccination side effects. A kitten with panleukopenia has a mortality rate exceeding 90%. A kitten with a vaccine reaction has a near-zero mortality risk. The calculus is not close. The feline medication dosage calculator covers common medications including antihistamines that veterinarians may prescribe for cats with a history of mild vaccine reactions.

Sources

Vaccination schedules and recommendations follow the WSAVA Guidelines for the Vaccination of Dogs and Cats (2024 revision), the AAFP Feline Vaccination Advisory Panel Report (2020), and the BSAVA Guide to Vaccination (2018). Maternal antibody kinetics reference Jakel et al. (2012), "Duration of Maternally Derived Antibodies Against Feline Panleukopenia Virus," published in Veterinary Microbiology. FeLV epidemiology and vaccine recommendations reference Hartmann (2012), "Feline Leukaemia Virus Infection," in Infectious Diseases of the Dog and Cat (4th edition). Feline injection-site sarcoma incidence data follows Martano et al. (2011), published in the Veterinary Journal, and the ABCD European Advisory Board on Cat Diseases guidelines. Panleukopenia mortality data references Kruse et al. (2010), "Prognostic Factors in Cats with Feline Panleukopenia," published in the Journal of Veterinary Internal Medicine. UK rabies-free status data from the Department for Environment, Food and Rural Affairs (DEFRA). The developmental milestone reference provides a comparable timeline for puppy vaccinations and development.